Identification and characterization of a novel heme-associated cell surface protein made by Streptococcus pyogenes

Benfang Lei1, Laura M Smoot, Heather M Menning

  • 1Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.

Insights

Researchers discovered a novel heme-associated protein (Shp) on the surface of Group A Streptococcus (GAS). This protein is produced in vivo and may be a target for developing new Group A Strep vaccines.

Area of Science:

  • Microbiology
  • Immunology
  • Molecular Biology

Background:

  • Group A Streptococcus (GAS) is a significant human pathogen causing various infections.
  • Understanding GAS virulence factors and host interactions is crucial for developing effective treatments and vaccines.

Purpose of the Study:

  • To identify and characterize novel cell surface proteins of GAS.
  • To investigate the role of a newly identified protein in GAS pathogenesis and host immune response.

Main Methods:

  • Genome sequence analysis of a serotype M1 GAS strain.
  • Gene cloning, protein overexpression in Escherichia coli, and purification.
  • Characterization of the protein's association with heme.
  • In vitro and in vivo production assessment using GAS cultures and infected animal models.
  • Immunization studies in mice to evaluate bactericidal activity.

Main Results:

  • A novel putative cell surface protein, designated Shp, was identified and characterized.
  • Shp was found to be associated with heme in a 1:1 stoichiometry.
  • GAS produces Shp in vitro, and it is located on the bacterial cell surface.
  • Shp is produced in vivo during GAS infections, as evidenced by seroconversion in infected mice and humans.
  • Active immunization with Shp significantly enhanced the bactericidal activity of mouse blood.
  • The shp gene is part of an operon potentially involved in iron uptake.

Conclusions:

  • Shp is a novel, cell surface-associated heme-binding protein of Group A Streptococcus.
  • Shp is expressed during infection and elicits an in vivo immune response.
  • Shp represents a potential target for therapeutic and vaccine development against GAS infections.

Related Concept Videos

Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...